Related Experiment Videos
Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy
Lotus Mallbris1, Anders Ljungberg, Mari-Anne Hedblad
1Unit of Dermatology, Department of Medicine, Karolinska Institute, 171 76 Stockholm, Sweden.
Journal of the American Academy of Dermatology
|February 13, 2003
Abstract:
We describe a patient with widespread and progressive cutaneous sarcoidosis who was successfully treated with anti-tumor necrosis factor-alpha monoclonal antibody, infliximab, suggesting that inhibition of tumor necrosis factor-alpha may be useful as targeted treatment in cutaneous sarcoidosis.